12:00 AM
 | 
Jul 02, 2001
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Genzyme General

(GENZ), Cambridge, Mass.

Business: Biopharmaceuticals

Merrill Lynch analyst Eric Hecht raised his 2001 and 2002 sales estimates...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >